ReviewBreast care (Basel, Switzerland)2023

HER2+ Early Breast Cancer: From Escalation via Targeted and Post-Neoadjuvant Treatment to De-Escalation.

Monika Graeser et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.